key: cord-0819635-qs5vyl6b
authors: Gupta, Radhika; Kumar, Prashant; Fahmi, Nighat; Garg, Bhaskar; Dutta, Sriparna; Sachar, Shilpee; Matharu, Avtar S.; Vimaleswaran, Karani S.
title: Endocrine Disruption and Obesity: A current review on Environmental Obesogens
date: 2020-06-30
journal: nan
DOI: 10.1016/j.crgsc.2020.06.002
sha: 3641ed2538375b20abace5144f640eece948a1fa
doc_id: 819635
cord_uid: qs5vyl6b

Abstract Obesity represents an important public health concern because it substantially increases the risk of multiple chronic diseases and thereby contributing to a decline in both quality of life and life expectancy. Besides unhealthy diet, physical inactivity and genetic susceptibility, environmental pollutants also contribute to the rising prevalence of obesity epidemic. An environmental obesogen is defined as a chemical that can alter lipid homeostasis to promote adipogenesis and lipid accumulation whereas an endocrine disrupting chemical (EDC) is defined as a synthetic chemical that can interfere with the endocrine function and cause adverse health effects. Many obesogens are EDCs that interfere with normal endocrine regulation of metabolism, adipose tissue development and maintenance, appetite, weight and energy balance. An expanding body of scientific evidence from animal and epidemiological studies has begun to provide links between exposure to EDCs and obesity. Despite the significance of environmental obesogens in the pathogenesis of metabolic diseases, the contribution of synthetic chemical exposure to obesity epidemic remains largely unrecognised. Hence, the purpose of this review is to provide a current update on the evidences from animal and human studies on the role of fourteen environmental obesogens in obesity, a comprehensive view of the mechanisms of action of these obesogens and current green and sustainable chemistry strategies to overcome chemical exposure to prevent obesity. Designing of safer version of obesogens through green chemistry approaches requires a collaborative undertaking to evaluate the toxicity of endocrine disruptors using appropriate experimental methods, which will help in developing a new generation of inherently safer chemicals.

Obesity is an important global health concern, as it is one of the main predisposing factors for the emerging epidemic of non-communicable diseases (NCDs) and recognised by the UN Sustainable Development Goals (1) . Nearly 30% of the total population are obese (~2.1 billion) and the worldwide obesity rate has tripled since 1975 (2) . While caloric excess, sedentary lifestyle and genetic susceptibility are classically identified as the main drivers of obesity (3, 4) , these factors alone do not fully account for the genesis and pattern of the obesity epidemic. Since late 19th century, the environment to which humans are exposed has changed due to the increased production of synthetic chemicals, which are also a potential risk factor of obesity (5) . These chemicals can interfere with the action of hormones, which are involved in regulating metabolism and weight gain, and are referred to as "environmental obesogens" that are thought to promote obesity by interfering with metabolic homeostasis (6) .

Although endocrine disruption has only recently received a great attention, the concept has been known about for a long time. Early indications of an endocrine-disrupting activity were reported in the 1920s using studies in pigs (7) . In 1960s, after exposure to industrial chemicals, endocrine disruption was reported widely in wildlife living on land, in water and in air. Today, humans are ubiquitously exposed to chemicals in daily life through their use in industrial and household products, pesticides, herbicides, plastics, detergents, flame retardants and personal care products. An expanding body of scientific evidence has begun to provide links between exposure to such chemicals and metabolic diseases such as obesity and diabetes (8, 9) . Evidence from research studies has shown that a variety of environmental chemicals can influence adipogenesis and obesity. Today, there are more than 1000 chemicals reported to have endocrine effects (10) .

Despite the significance of environmental obesogens in the pathogenesis of metabolic diseases, the contribution of synthetic chemical exposure to obesity remains largely unrecognised. Hence, the purpose of this review is to provide a current update on the evidences from animal and human studies on the role of environmental obesogens in obesity, a comprehensive view of the mechanisms of action of these obesogens and green and sustainable chemical strategies to overcome chemical exposure to prevent obesity.

In 2002, Baillie-Hamilton proposed a link between the increase in new industrial chemicals over the past four decades and the beginning of the obesity epidemic (11) suggesting that these so-called obesogens could have damaged many of the body's natural weight-control mechanisms. This correlation along with experimental evidence led to the environmental obesogens hypothesis by Grun and Blumberg in 2006 (12) . The hypothesis suggests that prenatal or early-life exposure to synthetic chemicals may predispose exposed individuals to increased fat mass and excess weight. Studies in animal models have shown that certain environmental pollutants induce adipogenesis (i.e., formation of adipocytes (fat cells) from stem cells) and weight gain that is suggestive of the causative role of synthetic chemicals in the pathogenesis of obesity (13) .

Endocrine Disrupting Chemicals (EDCs) are exogenous chemicals that interfere with the action of hormones. EDCs are used in everyday products from food packaging to fungicides and found abundant in our environment. Exposure to EDCs during early years of development have been shown to increase the risk of developing various chronic diseases including obesity and diabetes (14) . EDCs cause weight gain by altering lipid metabolism to promote adipogenesis and lipid accumulation (15) . This has been shown to occur through the following mechanisms (16, 17) : (i). increasing the number and size of adipocytes and storage of fat per cell, (ii). altering endocrine pathways responsible for control of adipose tissue development, hormones that regulate appetite, satiety, and food preferences, basal metabolic rate, energy balance to favour storage of calories and insulin sensitivity and lipid metabolism in endocrine tissues such as pancreas, adipose tissue, liver, gastrointestinal tract, brain, and muscle.

The effect of EDCs on adipogenesis and obesity gained further attention after the postulation of the environmental obesogens hypothesis. These effects often begin during development, lead to obesity later in life (15) . Many environmental obesogens are EDCs that interfere with normal endocrine metabolic regulation, adipose tissue development and maintenance, appetite, weight and energy balance (18) .

Studies have indicated that EDCs/ obesogens are likely to increase the number and size of adipocytes by interfering with transcriptional regulators that control lipid flux, adipocyte proliferation, and adipocyte differentiation, particularly through the peroxisome proliferator-activated receptors (namely, PPAR-γ). Activation of the retinoid X receptor (RXR)-PPAR-γ heterodimer favours the differentiation of pre-adipocytes in adipose tissue and regulates lipid biosynthesis and storage (16) . Besides PPARs, steroid hormones have also shown to influence lipid storage and fat deposition. Another mechanism of EDC action may be through disrupting the energy balance between energy intake and energy expenditure (19) , which has been shown to occur by either altering appetite, satiety, and food choices or through altering physical activity, resting metabolic rate, adaptive thermogenesis, and growth rates.

It has been shown that, during early stages of development, only low levels of EDCs are necessary to alter development as the protective mechanisms that exist in an adult such as the ability to repair DNA, a competent immune system, detoxifying enzymes, liver metabolism, the blood-brain barrier, and a normal metabolic rate may not yet be developed (9, 20) . However, longer exposure to EDCs is required for the development of obesity in adulthood (20) .

The first publications that provided a proof of principle for the ability of chemicals to induce obesity, which were in line with obesogens hypothesis, showed that smoking during pregnancy can increase weight gain in children. This was further confirmed in 2008, where a meta-analysis of 14 epidemiological studies showed a strong association between maternal smoking during pregnancy and weight gain in the children (21) . By 2013, this finding was replicated in 30 different epidemiological studies (22) . Furthermore, these results were confirmed in human studies where nicotine administration in pregnant mothers resulted in increased body weight and fat disposition, adipocyte size and expression of genes involved in adipogenesis (23) . These studies led to the discovery of nicotine as an endocrine disruptor.

Similarly, the role of polychlorinated biphenyls (PCBs) as endocrine disruptors/ obesogens was first shown by an epidemiological study (24) , which showed that women exposed to PCBs during pregnancy gave birth to girls who were heavier than other girls. shown to modulate estrogen receptor signalling and reverse truncal fat accumulation in postmenopausal women and in ovariectomized rodent models (19) . Male offspring of rodents treated with phytoestrogens during pregnancy or lactation developed obesity at puberty.

Neonatal exposure to diethylstilbestrol, a synthetic form of the female hormone estrogen, led to long-term weight gain in adulthood in female mice (28) , which suggested that EDCs with estrogenic activity may act to mimic estrogen action on adipogenesis.

Bisphenol A (BPA) belongs to the list of compounds that have the obesogenic property, as rodent models have shown that exposure to BPA is associated with weight gain (29) . One of the mechanisms by which BPA increases body weight is through the activation of PI-3 kinase (30) where BPA can push the fibroblastic cells into the adipocyte differentiation pathway leading to increased accumulation of triglycerides and lipoprotein lipase.

There are several environmental chemicals, which have been shown to act as EDCs.

This section will focus on some of the commonly identified EDCs, their mechanisms of action as obesogens including epigenetic and transgenerational effects, in addition to the data connecting exposures to obesity in human populations ( Table 1) . Epoxy resins are used as varnish to coat metal products such as food cans, bottle tops, and water supply pipes. BPA is also used as an additive in plastics such as polyvinyl chloride (PVC) and polyethylene terephthalate (PET) and is widely used in commercial products for many decades, but studies have shown that high levels of BPA may cause harm to both animals and humans (31, 53, 54) .

Studies have shown BPA to be an active agonist of estrogen-sensitive membrane receptor GPR30 and glucocorticoid receptors (31, 32) and it mimics the structure and function of the sex hormone estrogen and controls gene expressions to influence bodily processes, such as growth, cell repair and foetal development (53) . In addition, BPA may also interact and disrupt the functioning of thyroid gland (53) and affects the obesity-related biomarkers such as adiponectin, adipokine, leptin and ghrelin (31) . BPA has shown to increase the number and size of adipocytes by regulating the expression of genes such as fatty acid binding protein 4, (FABP4), cluster of differentiation 36 (CD36), and Proprotein convertase 1 (PCSK1) (55) and impair adipocyte metabolism (56) . Studies have shown that BPA exposure lowers the release of adiponectin which is a key player in lipid metabolism and fatty acid oxidation and decreased secretion of adiponectin deactivates fat combustion and hence leads to obesity-related metabolic syndrome (31) . BPA has also shown to promote adipogenesis by stimulating glucocorticoid receptors in combination with insulin in 3T3-L1 mouse fibroblasts cell lines (57) .

The effects of BPA exposure have been noticed in all age groups including neonates, children, and adults ( Table 2) . It has been found that prolonged or high exposure to BPA during the early life causes more adverse effects related to obesity in adulthood (58) .

Additionally, the World Health Organisation reported that BPA levels in breastfed babies were found to be nearly eight times lower than those fed on liquid formula using BPAcontaining bottles (59). Studies have also demonstrated a positive association between urinary BPA levels and obesity and diabetes in adults (60, 61) , children, and adolescents (62); however, a few studies have questioned the strength of the association (63) . Given the amount of research that has been carried out in relation to BPA as an obesogen, future prevention efforts should now be employed to avoid BPA exposure, and more research is required to identify the duration, dose, and impact of long-term exposure of BPA to clarify its risk assessment.

Phthalates, for example, diesters of 1,2-benzenedicarboxylic acid, are frequently used as plasticizers (64) . Phthalates have been considered as EDCs with anti-androgenic and weakly estrogenic properties (65) and studies have suggested that phthalates are likely to influence obesity through mechanisms such as anti-thyroid hormone activities, and/or activation of peroxisome proliferator-activated receptors, and epigenetic modulation (34, 66) .

Epidemiological studies in adults and children ( Table 2 ) have shown that higher concentrations of urinary phthalates were positively associated with obesity and cardiometabolic disease-related markers (67, 68) . However, inconsistent associations have been shown between early-life exposure to phthalate metabolites and childhood growth and obesity (69) (70) (71) . While a study in 520 French boys found that prenatal phthalate exposure was significantly associated with increased body mass index (BMI) at age 5 (72), a study in 1,239 from the US found that exposure to phthalates at ages 6-8 were associated with a predicted decrease in BMI from the ages of 7-13 (71) . Further large longitudinal studies in diverse study populations are required to confirm the relationship between phthalate exposure and obesity.

Atrazine [ATZ, 2-chloro-4-ethylamino-6-isopropylamino-1,3,5-triazine] is the second most extensively used herbicide in the Unites States (73), and Australian agriculture (74) .

Given its role as a photosynthesis inhibitor (75), it is used extensively to control pre-and post-emergence broadleaf and grassy weeds in crops predominately in corn and sugarcane.

ATZ functions by binding irreversibly to the plastoquinone binding protein of photosystem complex-II on thylakoid membranes in chloroplast and inhibiting the electron transfer and photosynthesis (76) . ATZ is also capable of binding to complex-I and III of the mitochondrial electron transport system and inhibiting the oxidative phosphorylation of mitochondria (36) .

As per the testing of United States Department of Agriculture, 94% of US drinking water contains atrazine as a contaminant and approximately 7 million people were exposed to atrazine between 1998 and 2003 (77) .

ATZ has been identified as a potent endocrine disruptor having androgenic inhibiting and weak estrogenic effects (78) . Animal studies have shown that long-term exposure to ATZ might contribute to the development of metabolic diseases outcomes such as insulin resistance and obesity, especially when exposure is linked with a high-fat diet (79) . In addition, the Agricultural Health Study in 11,273 pregnant mothers showed that women who reported agricultural exposure to herbicide, ATZ, during pregnancy had a risk of developing gestational diabetes (80) . Hence, environmental exposure to ATZ might be an important contributing factor to the obesity epidemic, as it results in damaging the mitochondrial function, affecting insulin signalling pathway, and inducing insulin resistance and obesity.

Organotin compounds are those chemicals in which a tin atom is covalently bonded to the carbon atom of one or more organic substituents. They are represented by the general formula RSnX, where R is an alkyl group (methyl, ethyl, butyl, octyl) or aryl group and X is an halide (Cl, F) or other organic ligand (oxide, hydroxide, carboxylate or thiolate etc.) (81, 82) . These compounds can be classified in four different classes for instance monoorganotins (RSnX 3 ), diorganotins (R 2 SnX 2 ), triorganotins (R 3 SnX) and tetraorganotins (R 4 Sn).

Organotins are industrially significant compounds which are widely used as polyvinyl chloride (PVC) stabilizers, biocides, or antifouling paints and have given rise to ubiquitous environmental contamination (83) . Organotin infamy is mainly due to trialkyltins (particularly tributyltin (TBT) and to lesser extent triphenyltin (TPT), active ingredients in antifouling paint formulations, especially for external marine applications. Thus, TBT is released into water and because of its low water solubility it gets deposited in sediments, resulting in the adverse and inexplicable effects on aquatic organisms (84) . Since, organotins are used in plastics, silicone and foams, therefore it results in their presence almost everywhere in clothes, wallpaper, medical devices, household piping, food containers and toys. Hence, humans are largely exposed to organotins not only through contaminated seafood but also through direct contact with these products and by ingestion and inhalation of dust. Organotins have been detected in human tissue samples and toxicity data has identified these compounds as carcinogens, endocrine disruptors, immunotoxicants and obesogens (12) .

Organotins induce their metabolic-and endocrine-disrupting effects by interacting with transcriptional regulators such as nuclear and steroid receptors and thereby affecting different nuclear receptor signalling pathways and resulting in various morphophysiological effects (85) . These chemicals exert their obesogenic effect not only by stimulating adipogenesis by acting as agonist ligands for nuclear receptors PPARγ but also potentially affecting RXR/PPARγ signalling (86) . TBT has shown to increase the expression of adipocyte markers, lipid accumulation and glucose uptake in preadipocytes and induce the differentiation of pre-adipocytes to adipocytes by activating RXR and PPARγ (86) . Besides studies investigating the effects of TBT on the hypothalamic-pituitary-thyroid axis, there is a frame of facts indicating that TBT can also be considered a thyroid disruptor, thus ultimately contributing to the development of metabolic disorder and obesity (87, 88) .

Organophosphates (also known as phosphate esters) are a class of organophosphorus compounds with the general structure O=P(OR) 3 Previously organophosphate insecticides had been associated with neuropsychological conditions, but more recently and specifically, the concepts of obesogens is being investigated and researchers began to look at its effect on the endocrine system. A strict link has been reported between the early-life exposure to organophosphates (chlorpyrifos, diazinon or parathion in doses devoid of any acute signs of toxicity) in neonatal rats and the subsequent emergence of hyperinsulinemia and hyperlipidemia, depicting an overall pattern essentially resembling prediabetes, through the pathway synthesizing cyclic AMP controlled by adenylyl cyclase, the common site for disruption by organophosphates (91) . In addition, dietary chronic exposure to chlorpyrifos, has been shown to increase food intake and promote weight gain in mice with apolipoprotein E3 isoform unravelling relevant interactions between toxic exposure to chlorpyrifos and genetic predisposition (92) . A recent study in mice has shown that long-term exposure to chlorpyrifos alters the gut microbiome leading to weight gain and reduced insulin sensitivity (93) . Besides animal studies, a study in organophosphateexposed cohort (N = 7,561) and an age-and gender-matched control cohort (N = 30, 244) showed that patients with acute poisoning from organophosphates had higher incidence rates of cardiovascular diseases compared with that of the non-organophosphatepoisoning cohort (94) . Given that obesity is a risk factor for CVDs, the impact of organophosphates on CVDs could possibly be mediated through obesity.

MSG is the sodium salt of glutamic acid [C 5 H 8 NO 4 Na], which is one of the most abundant naturally occurring non-essential amino acids. It is found naturally in algae, mushrooms, tomatoes and grapes. Today, MSG is artificially manufactured by the large-scale fermentation of starch for use in processed frozen foods, potato chips, salty snacks, sauces and sausages.

Lately, there has been a growing concern over MSGs being suspected as dietary obesogens which may be attributed to the altered regulatory mechanisms that hamper the fat metabolism (95) . 

Clozapine is a dibenzo-diazepine derivative, which shows strong antagonism towards several neurotransmitter receptors and is more effective in treating schizophrenia-related symptoms (99) . Prolonged use of clozapine has found to cause drug-induced metabolic syndrome in mammals that gave rise to adverse metabolic side effects such as obesity (100) .

It has been shown that clozapine alters the function of key metabolic enzymes and affects electron transport chain during oxidative phosphorylation in the mitochondria (100).

Furthermore, clozapine treatment has been associated with increased production of reactive oxygen species (ROS) and antioxidant proteins in cells and tissues (101, 102) . Studies have shown mitochondrial dysfunction, increased production of ROS and inflammation as mechanisms which are related to the development of obesity (103) . In addition, clozapine has been found to induce a preference for high-fat/high-sugar foods in both rats (104) and humans (105) . Animal studies have shown that clozapine blocks muscarinic M1 and M2 receptors and inhibits GLP-1 secretion (104) which influences the food preference and the secretion of high glucagon that affects the glucose homeostasis leading to impaired glucose tolerance and increase body weight. Experimental results also support their endocrine disrupting properties including disturbances in reproductive and metabolic physiology (106) . A study in 448

British mother-daughter dyads showed that prenatal exposure to PCBs was inversely associated with daughters' birth weight (24) .

Animal studies have shown that PCB-153 (2,2′,4,4′,5,5′-hexachlorobiphenyl) (107), the most prevailed congener in human serum, significantly increased body weight in mice that were fed with high fat diet (HFD) suggesting that PCB-153 is a diet-dependent obesogen (108) . It was hypothesised that PCB-153 causes obesity by stimulating the production of abnormal adipocytokines and altering hepatic lipid metabolism, which might lead to the upregulation of lipid biosynthesis gene expression and down-regulating beta-oxidation genes (108) . However, studies focussing on the precise mechanism by which PCB-153 cause obesity are highly warranted. PCBs, they also tend to accumulate in adipose tissue because of their persistent nature and lipophilicity (111) . PBDEs have been shown to disrupt endocrine homeostasis by reducing the thyroxine levels (T4) in the plasma of mice and rats and this has shown to disrupt lipid metabolism (112, 113) . Animal studies have also shown that upon exposure to penta-BDE (Pentabromodiphenyl ether -a technical mixture of different PBDE congeners), an increase in lipolysis and reduction in glucose oxidation was observed; both of these characteristics are associated with obesity (45) . The present understanding of the environmental behaviour of PBDEs as an obesogen is far from complete and hence further research is necessary to more fully understand their role as an EDC.

Perfluorooctanoic acid (PFOA) is a surfactant, which is used in non-stick cookware, waterproof clothing and stain repellent on carpets, mattresses and microwaveable food items (95) . PFOA has a tendency to accumulate in liver and kidney and has a mean serum half-life of four years. Due to its structural resemblance to fatty acids, it has been found to activate peroxisome proliferator-activated receptor (PPAR-α), which is a key transcription factor in lipid metabolism. Animal studies have shown that mice exposed prenatally to PFOA were more likely to become obese than controls when they reached adulthood (114) . Furthermore, PFOA exposed HFD-fed mice showed significant increase in body weight and peripheral adipose tissues. Exposure to PFOAs during development has also shown to increase insulin, leptin and body weight during mid-life (114) . However, it is still not clear whether PFOAs contribute to obesity in humans; hence, epidemiological studies in humans are required to establish a relationship between PFOAs and obesity.

Genistein is the most active isoflavone (Figure 1) found predominantly in legumes and it has attracted much attention of the scientific community as an angiogenesis inhibitor and a phytoestrogen (115) . Besides, it has also proven to be promising in the treatment of metabolic disorders owing to its antioxidant and anti-inflammatory activities (116) .

Interestingly, at low doses, genistein was shown to be responsible for changes in the expression of metabolic and adipogenic regulators, such as PPAR-γ, thus promoting fat accumulation in adipose tissue, especially in male mice (47) . A study in rats has also shown that genistein can dysregulate the body composition, in a dose-dependent and gender-specific manner, thereby disrupting and reprogramming the signals dictating adipose tissue expansion, likely throughout the early-life epigenetic regulation of Wnt10b, one of the key adipogenic genes in adipose tissue (117) . Studies in humans have shown that genistein intake is associated with decreased BMI, weight, waist circumference, and total body fat mass in postmenopausal women (118) . However, the mechanisms by which genistein has its beneficial effect on obesity is still unclear.

The term 'heavy metals' simply refers to metals having high densities, atomic numbers or weights, and are toxic at relatively low concentrations. Heavy metals belong to many aspects of modern human life (plastics, mobile phone, solar panels, antiseptics, and many more) and pose serious threat on human health (119, 120) as they cannot be destroyed or degraded, and tend to bioaccumulate. Whereas heavy metals such as iron (Fe), cobalt (Co), and zinc (Zn) are considered as essential nutrients to humans.

Animal and human studies have shown that consuming As-contaminated water can significantly increase leptin levels in the serum of the offspring of pregnant rodents and women, placental tissue, and cord blood (121) (122) (123) . Epidemiological studies have shown that individuals living in those areas with high exposure to As had an increased risk of developing type 2 diabetes (49). The mechanisms by which As is likely to increase the risk of diabetes in humans could be through the impairment of glucose-stimulated insulin secretion in pancreatic beta-cells, stimulation of pancreatic oxidative damage and insulin resistance in skeletal muscle, increment of gluconeogenesis in liver, and modulation of other hepatic insulin signalling pathways (124) (125) (126) (127) (128) . Furthermore, studies have shown that arsenobetaine (Figure   1 ), an organoarsenic compound that is the main source of arsenic found in fish, can accumulate in human body or transform into toxic inorganic arsenic in the gastrointestinal tract by microorganisms (129) . A study in 369 individuals from the Korean Korea National

Health and Nutrition Examination Survey demonstrated a significant association between urine arsenobetaine and pancreatic β-cell function (HOMA-β), which has been shown to be influenced by obesity (130) .

Cd is a well-known human carcinogen ranked seventh on the list of toxicants of potential concerns as declared by the Agency for Toxic Substances and Disease Registry. Pb is another highly toxic and carcinogenic metals for humans with no safe blood levels as identified by the Centers for Disease Control and Prevention (CDC) (131) . Exposure to both Cd and Pb heavy metals, especially, during the prenatal period has been shown to be associated with lower birth weight and gestational age in humans (132) (133) (134) . Similar to those of human studies, animal studies of perinatal Pb exposure has also been identified to increase body weight, fat mass or food intake in adulthood (135, 136) . Likewise, Cd exposure during early life has also been shown to increase fat mass in male mice. Studies have also shown that inflammation, oxidative stress, and insulin resistance (137) may also play vital roles in Cd and Pb-induced obesity.

DDT is a colourless, odourless and first modern synthetic organochlorine insecticide ( Figure  1 ) developed in 1940s. DDT and its metabolite product, dichlorodiphenyldichloroethylene (DDE), have been shown to be associated with adverse health problems which include diabetes and obesity in children (138) . Animal studies have shown that ancestral exposure to DDT can result in obesity transgenerationally suggesting that the etiology of obesity may in part be due to environmentally induced epigenetic transgenerational inheritance (139) . A study in rats have shown that exposure to DDE impairs the function of visceral adipose tissue and decreases the response to energy surplus, thereby contributing significantly to metabolic dysfunction and inflammation (140) . Cell line studies have shown that DDT can target PPARγ by increasing its expression or binding to it directly to activate downstream cascades that eventually leads to enhanced adipogenesis (50) . Besides affecting PPARγ, DDT has also shown to directly increase the expression of genes such as involved in lipid storage in adipocytes (50) . Given the role of DDT in endocrine diseases, a more careful risk consideration of the use of DDT is required.

Nicotine is found in the tobacco plant which is indigenous to the Americans and has been used as medicine and stimulant for at least 2000 years. Epidemiological studies showed that maternal smoking in pregnancy is a major risk factor for obesity even when exposure is limited only to early pregnancy stage (141, 142) . Studies have shown that prenatal nicotinic overload prevents sympathetic responsiveness, which can lead to peripheral as well as central underactivity of noradrenergic systems; this in turn may increase appetite and decrease mobilization of fat from adipose tissue (143) . Additional studies are required to assess whether nicotine exposure in early pregnancy increases long-term risk of obesity and its related disease outcomes. 

Epigenetics is the study of heritable patterns of phenotype resulting from changes in a chromosome without alterations in the DNA sequence. In other words, epigenetic modifications refer to changes in the gene expression that are not caused by changes in the DNA sequences but are due to events such as DNA methylations and histone modifications (165) . Research in the field of EDCs has now focused on the effects of chemical exposures on the development of obesity through modulation of the epigenome during in utero and early postnatal stage. Exposure to a EDC appears to modify the epigenome, and available evidence demonstrates that chemical-induced epigenetic changes can be heritable (166) .

Hence, exposure to EDCs may influence the metabolic status of an individual, with the potential for these effects to be transmitted to subsequent generations.

Even though there is no direct evidence to support an association of epigenetic mechanism for the actions of these environmental obesogens, studies in agouti mouse model offer a glimpse of this association (167 (171) . Furthermore, exposure to PM10 was also linked to asthma and bronchitis. Given the data from these studies, it could be hypothesized that exposure to air pollutants might have an impact on the prognosis of SARS. Human studies have shown that nitrogen dioxide (NO 2 ), which is one of the components of air pollution, was associated with higher fasting serum lipids among obese people suggesting obesity may exacerbate the effects of air pollution (172) . Animal studies have also shown that early-life exposure to air pollution particulates can lead to increased visceral obesity, insulin resistance, and inflammation suggesting the role of NO 2 as an endocrine disruptor (173) . Given that COVID-19 is similar to SARS in causing respiratory illness, it is possible that exposure to NO 2 could increase the mortality rate among COVID-19 patients; however, future studies are required to confirm this relationship.

To overcome the detrimental effects of obesogens on metabolic health, implementation of strategies such as expanded research programs and workshops, public health policies, and education efforts are highly warranted. Endocrine disruptor screening programs have been developed by the Environmental Protection Agency to assess the chemicals for their endocrine-disrupting effects (174) and this initiative should be expanded to identify obesogens and the molecular mechanisms by which they affect the metabolic health to specifically identify life-threatening chemicals. In addition, risk analysis should be developed by identifying groups who are exposed to high-risk obesogens and factors such as genetic variations that are linked to detoxification and metabolic pathways. Furthermore, instead of directly measuring the EDCs (175), development of clinical biomarkers will be useful in identifying individuals who are exposed to the obesogens and who can be prospectively monitored for the development of metabolic diseases such as obesity. Strategies to limit the production and the use of chemicals that affect the metabolic health and to ban the chemicals that are likely to induce transgenerational effects should be implemented.

One of the important goals of green and chemistry is to avoid the hazardous exposure to these environmental obesogens/ EDCs by designing a safer version of these synthetic chemicals (176) . This can be achieved by understanding the obesogen's potential hazardous effect as early in the design process, which will enable the chemists to design new chemicals without these harardous effects. For instance, an endocrine disruption testing protocol has been developed for new chemical design by a team of 23 scientists and this protocol aims at measuring potential hormone-like or hormone-inhibiting effects of obesogens (177) . In addition, given the rapid advances in science, new assays are being incorporated into the protocol.

In conclusion, further experimental and epidemiological approaches are necessary to fully establish a magnitude of potentially hazardous effects of obesogens in humans, and its association to obesity and its related diseases. Research focussing on understanding the role of environmental obesogens in the epidemics of obesity is in an infant stage; hence, besides chemists, researchers from the field of genetics, molecular biology, epidemiology, physiology and clinical medicine are required to improve the understanding of the role of environment in obesity. For the design of safer version of obesogens through green chemistry approaches, a collaborative undertaking among the chemist, toxicologists and scientists is required; this will permit the evaluation of toxicity using appropriate experimental methods and will help lead to a new generation of inherently safer chemicals. These collaborative approaches will also educate the public and the lawmakers about the threat of endocrine disruptors and will limit the use of such obesogens through the implementation of public health policies. To overcome the challenges involved in studying the risk of obesity in relation to environmental obesogen exposures during early life, large sample size, prospective study designs, well characterised assessment of exposure and advanced statistical analysis are required to provide a strong evidence base for recommendations and strategies to prevent obesity and other related diseases.

Continued improvements in global legislation and adoption of practices such as, Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), in concert with regulatory bodies and non-governmental organisations will see a move to safer alternatives enabling better green and sustainable chemistry. 

The obesity transition: stages of the global epidemic

Progress in the genetics of common obesity and type 2 diabetes

Interaction between FTO gene variants and lifestyle factors on metabolic traits in an Asian Indian population

The paradox of progress: environmental disruption of metabolism and the diabetes epidemic

Role of environmental chemicals in obesity: a systematic review on the current evidence

Vulvo-vaginitis in swine: preliminary report

Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review

Role of nutrition and environmental endocrine disrupting chemicals during the perinatal period on the aetiology of obesity

Endocrine Disruptors: Past Lessons and Future Directions

Chemical toxins: a hypothesis to explain the global obesity epidemic

Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling

Endocrine disruptors: from endocrine to metabolic disruption

Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders

Comparative Overview of the Mechanisms of Action of Hormones and Endocrine Disruptor Compounds

Endocrine disrupters as obesogens

Endocrine Disruptors and Obesity

Metabolism disrupting chemicals and metabolic disorders

Maternal smoking during pregnancy and child overweight: systematic review and meta-analysis

Evaluation of the association between maternal smoking, childhood obesity, and metabolic disorders: a national toxicology program workshop review

Effects of nicotine during pregnancy: human and experimental evidence

Prenatal exposure to polychlorinated biphenyls and fetal growth in British girls

DDT metabolites and pregnancy outcomes

Childhood obesity and environmental chemicals

Prenatal exposure to the environmental obesogen tributyltin predisposes multipotent stem cells to become adipocytes

Diethylstilbesterol has gender-specific effects on weight gain and bone development in mice

Bisphenol A: Perinatal exposure and body weight

Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway

Perinatal Exposure to Low-Dose Bisphenol-A Disrupts the Structural and Functional Development of the Hypothalamic Feeding Circuitry

Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption

Low-Dose Bisphenol-A Impairs Adipogenesis and Generates Dysfunctional 3T3-L1 Adipocytes

Casals-Casas C. PPAR-mediated activity of phthalates: A link to the obesity epidemic?

Exposure to Phthalate, an Endocrine Disrupting Chemical, Alters the First Trimester Placental Methylome and Transcriptome in Women

Atrazine exposure causes mitochondrial toxicity in liver and muscle cell lines

Atrazine acts as an endocrine disrupter by inhibiting cAMP-specific phosphodiesterase-4

Organotins in obesity and associated metabolic disturbances

N-acetyl cysteine attenuates diazinon exposure-induced oxidative stress in rat testis

The endocrine disrupting potential of monosodium glutamate (MSG) on secretion of the glucagon-like peptide-1 (GLP-1) gut hormone and GLP-1 receptor interaction

Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate

Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever

Obesity and persistent organic pollutants: possible obesogenic effect of organochlorine pesticides and polychlorinated biphenyls

Endocrine-disrupting actions of PCBs on brain development and social and reproductive behaviors

Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism. Obesity (Silver Spring)

Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR

Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner

Genistein--a dietary compound inducing hormonal and metabolic changes

Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiological evidence

The Effects of Endocrine Disruptors on Adipogenesis and Osteogenesis in Mesenchymal Stem Cells: A Review

Early developmental actions of endocrine disruptors on the hypothalamus, hippocampus, and cerebral cortex

The endocrine effects of nicotine and cigarette smoke

Human Bisphenol A Exposure and the "Diabesity Phenotype

Association of exposure to Bisphenol A with obesity and cardiometabolic risk factors in children and adolescents

The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity

Getting big on BPA: role for BPA in obesity?

Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation

The Association between Bisphenol A Exposure and Obesity in Children-A Systematic Review with Meta-Analysis

Urinary bisphenol A and obesity: NHANES 2003-2006

Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance

Association of early life exposure to bisphenol A with obesity and cardiometabolic traits in childhood

Bisphenol A and indicators of obesity, glucose metabolism/type 2 diabetes and cardiovascular disease: a systematic review of epidemiologic research

Human exposure to phthalates via consumer products

Differential effects of phthalate esters on transcriptional activities via human estrogen receptors alpha and beta, and androgen receptor

Phthalate exposure and childhood obesity

Race/ethnicity-specific associations of urinary phthalates with childhood body mass in a nationally representative sample

Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a crosssectional study of NHANES data

Prenatal Exposure to Phthalates and Childhood Body Size in an Urban Cohort

Association of prenatal urinary phthalate metabolite concentrations and childhood BMI and obesity

Longitudinal Associations of Phthalate Exposures During Childhood and Body Size Measurements in Young Girls

Phthalate pregnancy exposure and male offspring growth from the intra-uterine period to five years of age

Pesticide industry sales and usage: 2000 and 2001 market estimates

Atrazine Chemical Review: Australian Pesticides and Veterinary Medicines Authority: Australian Pesticides and Veterinary Medicines Authority

Mixture toxicity of three photosystem II inhibitors (atrazine, isoproturon, and diuron) toward photosynthesis of freshwater phytoplankton studied in outdoor mesocosms

Herbicides in the great lakes

United States Geological Survey, Measured Atrazine in Streams

Effect of endocrine disruptor pesticides: a review

Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance

Pesticide exposure and selfreported gestational diabetes mellitus in the Agricultural Health Study

Occurrence and chemical speciation analysis of organotin compounds in the environment: a review

Integrated Human and Ecological Risk Assessment: A Case Study of Tributyltin and Triphenyltin Compounds

The Industrial Use of Tin Chemicals

Pollution history and sources of organotin compounds in aquaculture water of Tong'an Bay

Endocrine disruption induced by organotin compounds; organotins function as a powerful agonist for nuclear receptors rather than an aromatase inhibitor

Organotins are potent activators of PPARgamma and adipocyte differentiation in bone marrow multipotent mesenchymal stromal cells

Disruptive Effect of Organotin on Thyroid Gland Function Might Contribute to Hypothyroidism

Frontiers in endocrine disruption: Impacts of organotin on the hypothalamus-pituitary-thyroid axis

Organophosphate toxicity and occupational exposure

Chronic exposure to organophosphate (OP) pesticides and neuropsychological functioning in farm workers: a review

Does early-life exposure to organophosphate insecticides lead to prediabetes and obesity?

Chronic exposure to chlorpyrifos triggered body weight increase and memory impairment depending on human apoE polymorphisms in a targeted replacement mouse model

Organophosphorus pesticide chlorpyrifos intake promotes obesity and insulin resistance through impacting gut and gut microbiota

The Long-Term Effects of Organophosphates Poisoning as a Risk Factor of CVDs: A Nationwide Population-Based Cohort Study

Obesogens: an environmental link to obesity

Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP Study

Consumption of monosodium glutamate in relation to incidence of overweight in Chinese adults: China Health and Nutrition Survey (CHNS)

Monosodium glutamate (MSG) intake is associated with the prevalence of metabolic syndrome in a rural Thai population

Fernandez-Egea E. A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome

Clozapineinduced mitochondria alterations and inflammation in brain and insulin-responsive cells

Effects of antipsychotics and vitamin C on the formation of reactive oxygen species

Haloperidoland clozapine-induced oxidative stress in the rat brain

Mitochondrial oxidative stress and inflammation: an slalom to obesity and insulin resistance

Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour

Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone

Transgenerational effects of polychlorinated biphenyls: 1. Development and physiology across 3 generations of rats

National Toxicology P. NTP technical report on the toxicology and carcinogenesis studies of

Polychlorinated biphenyl 153 is a diet-dependent obesogen that worsens nonalcoholic fatty liver disease in male C57BL6/J mice

Overview of air pollution and endocrine disorders

Is the current-use flame retardant, DBE-DBCH, a potential obesogen? Effects on body mass, fat content and associated behaviors in American kestrels

In vitro profiling of the endocrine-disrupting potency of brominated flame retardants

Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects

Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice

Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life

Biological properties of genistein. A review of in vitro and in vivo data

Genistein: a promising therapeutic agent for obesity and diabetes treatment

Genistein exposure during the early postnatal period favors the development of obesity in female, but not male rats

Usual dietary isoflavone intake and body composition in postmenopausal women

Inorganic arsenic exposure and its relation to metabolic syndrome in an industrial area of Taiwan

Effect of chronic exposure to cadmium on serum lipid, lipoprotein and oxidative stress indices in male rats

Effects of in Utero Exposure to Arsenic during the Second Half of Gestation on Reproductive End Points and Metabolic Parameters in Female CD-1 Mice

Association between maternal urinary arsenic species and infant cord blood leptin levels in a New Hampshire Pregnancy Cohort

Arsenicassociated oxidative stress, inflammation, and immune disruption in human placenta and cord blood

Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells

Arsenite reduces insulin secretion in rat pancreatic beta-cells by decreasing the calcium-dependent calpain-10 proteolysis of SNAP-25

Arsenic Induces Insulin Resistance in Mouse Adipocytes and Myotubes Via Oxidative Stress-Regulated Mitochondrial Sirt3-FOXO3a Signaling Pathway

Arsenic induces diabetic effects through beta-cell dysfunction and increased gluconeogenesis in mice

Acute and long-term effects of arsenite in HepG2 cells: modulation of insulin signaling

Accumulation or production of arsenobetaine in humans?

Association of arsenobetaine with beta-cell function assessed by homeostasis model assessment (HOMA) in nondiabetic Koreans: data from the fourth Korea National Health and Nutrition Examination Survey (KNHANES)

CDC updates guidelines for children's lead exposure

Lead exposure and birth outcomes in five communities in Shoshone County, Idaho

Effect of maternal lead burden on infant weight and weight gain at one month of age among breastfed infants

Effects of gestational cadmium exposure on pregnancy outcome and development in the offspring at age 4.5 years

Perinatal Lead Exposure Alters Gut Microbiota Composition and Results in Sex-specific Bodyweight Increases in Adult Mice

Early-life lead exposure results in dose-and sex-specific effects on weight and epigenetic gene regulation in weanling mice

Lead Exposure Induces Weight Gain in Adult Rats, Accompanied by DNA Hypermethylation

In utero DDT and DDE exposure and obesity status of 7-year-old Mexican-American children in the CHAMACOS cohort

Ancestral dichlorodiphenyltrichloroethane (DDT) exposure promotes epigenetic transgenerational inheritance of obesity

Adipose tissue dysfunction as a central mechanism leading to dysmetabolic obesity triggered by chronic exposure to p

Maternal smoking very early in pregnancy is related to child overweight at age 5-7

Association of early and late maternal smoking during pregnancy with offspring body mass index at 4 to 5 years of age

Handbook of developmental neurotoxicology

Urinary bisphenol A and obesity in U.S. children

Urinary Bisphenols and Obesity Prevalence Among U.S. Children and Adolescents

Bisphenol A substitutes and obesity in US adults: analysis of a population-based, cross-sectional study

In utero exposure to atrazine analytes and early menarche in the Avon Longitudinal Study of Parents and Children Cohort

A longitudinal study of atrazine and 2,4-D exposure and oxidative stress markers among iowa corn farmers

Association of placenta organotin concentrations with growth and ponderal index in 110 newborn boys from Finland during the first 18 months of life: a cohort study

Occurrence of Butyltin Compounds in Human Blood

Hormonal correlates of clozapine-induced weight gain in psychotic children: an exploratory study

Weight gain in children and adolescents during 45 weeks treatment with clozapine, olanzapine and risperidone

Predicting Weight Gain in Patients Treated With Clozapine: The Role of Sex, Body Mass Index, and Smoking

Prenatal exposure to polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) may influence birth weight among infants in a Swedish cohort with background exposure: a cross-sectional study

Prenatal Polybrominated Diphenyl Ether Exposure and Body Mass Index in Children Up To 8 Years of Age

Perfluorooctanoic Acid (PFOA) Exposure in Early Life Increases Risk of Childhood Adiposity: A Meta-Analysis of Prospective Cohort Studies

Early life perfluorooctanoic acid (PFOA) exposure and overweight and obesity risk in adulthood in a community with elevated exposure

Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects

Cadmium exposure increases the risk of juvenile obesity: a human and zebrafish comparative study

Arsenic methylation capacity and obesity are associated with insulin resistance in obese children and adolescents

Obesity and excess weight in early adulthood and high risks of arsenic-related cancer in later life

Prenatal DDT exposure and child adiposity at age 12: The CHAMACOS study

Passive Smoke Exposure and Its Effects on Cognition, Sleep, and Health Outcomes in Overweight and Obese Children

Relationship between smoking and obesity: a cross-sectional study of 499,504 middle-aged adults in the UK general population

Epigenetic modifications and human disease

Epigenetics and environmental chemicals

The agouti mouse model: an epigenetic biosensor for nutritional and environmental alterations on the fetal epigenome

Maternal genistein alters coat color and protects Avy mouse offspring from obesity by modifying the fetal epigenome

Transgenerational epigenetic effects of the endocrine disruptor vinclozolin on pregnancies and female adult onset disease

Air pollution and case fatality of SARS in the People's Republic of China: an ecologic study

Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution

Associations of air pollution, obesity and cardiometabolic health in young adults: The Meta-AIR study

Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model

Application of Adverse Outcome Pathways to U.S. EPA's Endocrine Disruptor Screening Program

Analytical methodologies for the determination of endocrine disrupting compounds in biological and environmental samples

The incorporation of hazard reduction as a chemical design criterion in green chemistry

Designing Endocrine Disruption Out of the Next Generation of Chemicals

• Many environmental obesogens are endocrine disrupting chemicals that interfere with normal endocrine regulation of metabolism, adipose tissue development and maintenance, appetite, weight and energy balance.• Understanding the role of environmental obesogens in the epidemics of obesity is in an infant stage.• Green chemistry approach aims to design a safer version of these synthetic chemicals, which can be achieved by understanding the obesogen's potential hazardous effect as early in the design process.• Further experimental and epidemiological approaches are necessary to fully establish a magnitude of potentially hazardous effects of obesogens in humans, and its association to obesity and its related diseases.

Radhika Gupta, Prashant Kumar, Nighat Fahmi, Bhaskar Garg, Sriparna Dutta, Shilpee Sachar, Avtar S Matharu, Karani S Vimaleswaran